Gabriel M.I. Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, Inc. (NYSE:HNGE), filed a Form 4 on September 15, 2026, disclosing the conversion of 150,000 Class B shares and the subsequent sale of 149,700 Class A Common Stock shares on September 14, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Conversion: 150,000 shares of Class B Common Stock were converted into 150,000 shares of Class A Common Stock at $0 on September 14, 2026.
  • Total shares sold: 149,700 Class A Common Stock shares were sold across six transactions on September 14, 2026, at weighted average prices ranging from $88.9793 to $94.7033.
  • Rule 10b5-1 plan: All sales were made pursuant to a trading plan adopted by the reporting person on June 12, 2026.
  • Resulting direct ownership: Following all reported transactions, Mecklenburg held 0 shares of Class A Common Stock directly.
  • Indirect holdings remaining: Mecklenburg retains 1,844,004 Class B shares directly, 383,592 Class A shares indirectly via a family trust, and 692,710 Class B shares indirectly via a GRAT.
  • Role: Mecklenburg is identified in the filing as a Director and Executive Chairman and Co-Founder of Hinge Health, Inc.

Mecklenburg Converts Class B Stock and Sells Resulting Class A Shares Under Pre-Planned Schedule

According to the filing, Gabriel M.I. Mecklenburg converted 150,000 shares of Class B Common Stock into 150,000 shares of Class A Common Stock at a price of $0 on September 14, 2026. The filing notes that each share of Class B Common Stock "is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation."

Following the conversion, the filing discloses six separate sale transactions of Class A Common Stock on the same date. The shares were sold in tranches of 2,800, 11,700, 16,540, 56,161, 33,501, and 29,298 shares at weighted average prices of $88.9793, $91.0924, $91.9197, $92.9957, $94.0326, and $94.7033, respectively. Each weighted average price represents a range of individual sale prices, with the lowest individual sale price reported as $88.75 and the highest as $94.79 across all tranches. All sales were made pursuant to a Rule 10b5-1 trading plan that Mecklenburg adopted on June 12, 2026.

After all reported transactions, Mecklenburg's direct beneficial ownership of Class A Common Stock was reduced to 0 shares, according to the filing. Indirect holdings disclosed include 383,592 Class A shares held by a family trust and, on the derivative securities table, 1,844,004 Class B shares held directly and 692,710 Class B shares held indirectly through a GRAT. The filing was signed by James Budge as Attorney-in-Fact on September 15, 2026.

What Was Disclosed

The filing reports a conversion of 150,000 Class B shares into Class A shares and the sale of 149,700 resulting Class A shares by Hinge Health's Executive Chairman and Co-Founder on September 14, 2026, under a Rule 10b5-1 plan adopted June 12, 2026.